2026. Evaluation of Clinical Outcome of 6 months Anti-TB therapy in Rifampicin sensitive Tubercular Cervical Lymphadenopathy in Tertiary Level Hospital, Dhaka, Bangladesh. The Planet. 10, 01 (Jul. 2026), 15–21. DOI:https://doi.org/10.5281/zenodo.21773667.